Vancouver, British Columbia, Canada Gibralt Capital Corporation appeared to be the VC, which was created in 1992. The company was established in North America in Canada. The leading representative office of defined VC is situated in the Vancouver.
The common things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2005. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2014.
Among the most popular portfolio startups of the fund, we may highlight Epirus Biopharmaceuticals. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. Among the most popular fund investment industries, there are Internet, Biotechnology.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Gibralt Capital Corporation, startups are often financed by Montreux Equity Partners, 5AM Ventures. The meaningful sponsors for the fund in investment in the same round are TPG Biotech, Mousse Partners, Montreux Equity Partners.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Axia8 Ventures | China, Shanghai, Shanghai |
| Banca Sella Group | Biella, Italy, Piemonte |
| Brevan Howard Investment Holdings | - |
| D&D Pharmatech | Kyonggi-do, Seongnam, South Korea |
| Extol Capital | Beverly Hills, California, United States |
| Gmarket | New York, New York, United States |
| GP Investments | Bermuda, Hamilton |
| Guangzhou Yuexiu Financial Holdings | China, Guangdong, Guangzhou |
| Hambledon Capital | - |
| Ladies Investment Club VC | - |
| Momentum Fund | - |
| MS&AD Insurance Group Holdings | Chiyoda, Japan |
| Overstock | Salt Lake City, United States, Utah |
| P18Ventures | Puerto Rico, San Juan, United States |
| Quadrant | Central, Central Region, Singapore |
| Raptor Consumer Partners | New York, New York, United States |
| RElab | England, London, United Kingdom |
| Saba Investments | - |
| SV-FINTECH Fund | Japan, Kanagawa Prefecture, Kawasaki |
| Wyss Zurich | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Epirus Biopharmaceuticals | $36M | 16 Apr 2014 | Boston, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Epirus Biopharmaceuticals | $36M | 16 Apr 2014 | Boston, Massachusetts, United States |
